24/7
Buzz
Startups
VC
AI
Innovation
Opinions
Events
Promising Startups 2026
2026 VC Survey
Boarding Pass
CTalk
BiblioTech
Corporate
Appointments
Tech Gateways
@Finance
Ctech Testimonials
Projects
About
Newsletter
Contact us
Facebook
Twitter
ACCESSIBILITY
by
Homepage
Clal Biotechnology Industries
Tags search
HOME
24/7
buzz
STARTUPS
VC
AI
Innovation
OPINIONS
EVENTS
Projects
ABOUT
teram of use
Privacy Policy
NEWSLETTER
SEARCH
CONTACT US
ACCESSIBILITY
24/7
Headlines
18:20
The World Cup warning: Riots don’t start in the streets. They start online
18:07
“There’s a price where you have to say yes”: CyberArk founder on the $25 billion Palo Alto deal
14:18
"If there is no significant change, we will see a 25%-30% reduction in high-tech's workforce"
13:32
“There is no better solution for Zim than the one we created”
More stories
Buzz
Most popular
Daily
Weekly
1
Jewish family from Mexico donates NIS 200 million to establish Israel's largest rehabilitation hospital
2
"If an engineer in Ireland costs 20% less, it is clearly part of the consideration when deciding where to expand"
3
Echo: “Employees have become very good at identifying performative culture”
4
After raising $20 million, collapsed startup Swish.ai sells to Unframe for just $150,000
5
Iron Dome and Iron Beam maker Rafael unveils new weapon against the drone threat
More news
Clal Biotechnology Industries
5 stories about Clal Biotechnology Industries
CBI plans to issue new SPAC to merge with Israeli life science company
18.03.21
|
Hezi Sternlicht
The Israeli biotech giant plans to raise $100 million on Nasdaq to acquire a company that’s involved in advanced healthcare solutions
Elicio Therapeutics enters Covid-19 vaccine race, reports success in pre-clinical trials
19.08.20
|
Sophie Shulman
Boston company partially owned by Clal Biotechnology Industries plans to advance to clinical trials in Q4
Sight Diagnostics raises $71 million amidst Covid-19 demand for blood count devices
26.07.20
|
CTech
Israeli startup develops machine vision-based technology for blood test analysis and infectious disease diagnosis
Cost-Cutting at CureTech Following Cancellation of Acquisition Deal with Insight
05.07.18
|
CTech
The deal was announced in March, but intended buyer InSight backed out
Three Portfolio Companies of Len Blavatnik's Clal Biotechnology Raise Cash in One Week
04.07.18
|
CTech
Clal Biotechnology Industries is an Israel-based life sciences investment company